BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Business

  MindChild Medical Inc. and the University of Oxford Announce a Sponsored Research Agreement for the Development of Innovative Signal Processing Software for Fetal and Maternal Monitor With the MERIDIAN™ Non-Invasive Fetal Heart Rate Monitor1

  November 5, 2012

   · 

  1 min read
• Bio NC

  Quintiles, Inc. Study Confirms Validity of Data From Patients Recruited Over the Internet

  November 5, 2012

   · 

  1 min read
• New Virttu Replicate Open Innovation Forum Provides Unique R&D Network for New Oncology Combination Therapies

  November 5, 2012

   · 

  1 min read
• BioMidwest

  Significant Blood Pressure Reduction From St. Jude Medical’s EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

  November 5, 2012

   · 

  1 min read
• Biotech Beach

  Aviir, Inc.'s CEO Dr. Douglas Harrington Delivered the Facts Surrounding Heart Disease at the Los Angeles Ultimate Women’s Expo

  November 5, 2012

   · 

  3 min read
• Drug Development

  Boehringer Ingelheim Pharmaceuticals, Inc. Release: RE-LY® Sub-Analysis Suggests Similar Safety and Efficacy With Pradaxa® (Dabigatran Etexilate Mesylate) Versus Warfarin in NVAF Patients With and Without Diabetes

  November 5, 2012

   · 

  8 min read
• Business

  Pharmacyclics, Inc. Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting

  November 5, 2012

   · 

  1 min read
• Pharm Country

  Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) Reports Third Quarter Financial Results and Updates 2012 Financial Guidance

  November 5, 2012

   · 

  1 min read
• Drug Development

  Omeros Corporation’ Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial

  November 5, 2012

   · 

  7 min read
• UK Government Awards £1.7 Million Grant to PsiOxus Therapeutics Limited for Second Phase I/II Clinical Trial of Cancer Vaccine

  November 5, 2012

   · 

  1 min read